*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
"The head of Marlboro cigarette-maker Philip Morris International (PMI) has hit out at critics of a controversial swoop on a healthcare company, claiming that the acquisition will help achieve its target to make the UK smoke-free within a decade. In the wake of fierce opposition to the deal to buy FTSE 250 inhaler-maker Vectura, André Calantzopoulos, PMI’s executive chairman, said the “obsessive focus” by anti-smoking campaigners on Big Tobacco was the “wrong approach”, adding that PMI has the “ability and the technology” to address harm from smoking.
